Autosomal dominant keratitis-ichthyosis-hearing loss syndrome: genes and variants
Explore variant evidence for Autosomal dominant keratitis-ichthyosis-hearing loss syndrome across 1 analyzed protein (GJB2). Linked ClinVar records include 13 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant keratitis-ichthyosis-hearing loss syndrome
GJB2: Gap junction beta-2 protein
Its connexin 26 channels support potassium and metabolite recycling within the cochlea and communication across epithelial gap junctions. Biallelic pathogenic variants are among the most common causes of congenital nonsyndromic hearing loss, while dominant variants can cause syndromic deafness with skin disease.
13 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in GJB2 have source records linked to Autosomal dominant keratitis-ichthyosis-hearing loss syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant keratitis-ichthyosis-hearing loss syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GJB2 I33T | 33 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 V43A | 43 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 R143Q | 143 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 R32L | 32 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 G45E | 45 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 A88V | 88 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 A88G | 88 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 R184W | 184 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 R127C | 127 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 N206S | 206 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GJB2 I20M | 20 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| GJB2 D50N | 50 | Extracellular | Pathogenic / likely pathogenic (★★) |
| GJB2 P175R | 175 | Extracellular | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Autosomal dominant keratitis-ichthyosis-hearing loss syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 92 out of 100
- SIFT: 90 out of 100
- AlphaMissense: 86 out of 100
- CADD: 86 out of 100
- phyloP: 68 out of 100
- Pangolin: 66 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 65 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal recessive nonsyndromic hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Autosomal dominant keratitis-ichthyosis-hearing loss syndrome variants (38 pathogenic / likely pathogenic).
- Nonsyndromic genetic hearing loss also has ClinVar records linked to GJB2 variants; they fall partly in the same places as the Autosomal dominant keratitis-ichthyosis-hearing loss syndrome variants (28 pathogenic / likely pathogenic).
- Rare genetic deafness also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant keratitis-ichthyosis-hearing loss syndrome variants (25 pathogenic / likely pathogenic).
- Mutilating keratoderma also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant keratitis-ichthyosis-hearing loss syndrome variants (15 pathogenic / likely pathogenic).
- Ichthyosis, hystrix-like, with hearing loss also has ClinVar records linked to GJB2 variants; they fall mostly in different places as the Autosomal dominant keratitis-ichthyosis-hearing loss syndrome variants (13 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant keratitis-ichthyosis-hearing loss syndrome
- Autosomal recessive nonsyndromic hearing loss, also linked to GJB2
- Noonan syndrome, also linked to GJB2
- Rare genetic deafness, also linked to GJB2
- Autosomal dominant nonsyndromic hearing loss, also linked to GJB2
- Nonsyndromic genetic hearing loss, also linked to GJB2
- Hearing loss, also linked to GJB2
- Monogenic hearing loss, also linked to GJB2
- Mutilating keratoderma, also linked to GJB2
- Ichthyosis, hystrix-like, with hearing loss, also linked to GJB2
- Knuckle pads, deafness AND leukonychia syndrome, also linked to GJB2
- Palmoplantar keratoderma-deafness syndrome, also linked to GJB2
- Deafness, also linked to GJB2
Frequently asked questions
Which genes have records linked to Autosomal dominant keratitis-ichthyosis-hearing loss syndrome?
This view contains 1 analyzed proteins: GJB2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 13 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 41 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center